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Objectives:  To determine if 2Flute otologic burs improve the size, cellular content and bone 
healing of autologous cortical bone grafts harvested during canal wall reconstruction 
tympanomastoidectomy with mastoid obliteration. 
Study Design:  IRB-approved prospective cohort study. 
Methods:  Human autologous cortical bone chips were harvested using various burs (4 and 6 
mm diameter; multiflute and 2Flute) from patients undergoing canal wall reconstruction 
tympanomastoidectomy for the treatment of chronic otitis media with cholesteatoma. Bone chip 
size, cell counts, cellular gene expression and new bone formation were quantified.  
Results:  Bone chips were significantly larger when harvested with 2Flute bur compared to 
multiflute burs at both 6mm diameter (113 ± 14 μm2 vs. 66 ± 8 μm2; P < 0.05) and 4mm diameter 
(70 ± 8 μm2 vs. 50 ± 3 μm2; P < 0.05). After 2 weeks in culture, cell numbers were significantly 
higher when harvested with 2Flute bur compared to multiflute burs at both 6 mm diameter (48.7 
± 3 vs. 31.8 ± 3 cells/μg bone; P < 0.05) and 4 mm diameter (27.6 ± 1.2 vs. 8.8 ± 1.2 cells/μg 
bone; P < 0.05). Bone derived cells express osteoblast markers (alkaline phosphatase, 
osteocalcin). Cultured cells are able to form new bone in culture and bone formation is facilitated 
by the presence of bone chips.  
Conclusions: Use of 2Flute otologic burs for human autologous cortical bone harvest results in 
more viable bone fragments with larger bone chips and more osteoblasts. Future studies are 
needed to determine if this leads to improved bone healing.  
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Introduction 
Canal wall reconstruction tympanomastoidectomy with mastoid obliteration (CWR) is 
used for the treatment of cholesteatoma in children and adults. The advantages of CWR include 
decreased recurrence of cholesteatoma compared to canal wall up (CWU) 
tympanomastoidectomy, increased intraoperative visualization of cholesteatoma similar to canal 
wall down (CWD) tympanomastoidectomy, while obviating the need for lifetime mastoid cavity 
cleanings or water activity restrictions1.  
The CWR procedure involves harvesting autologous bone pâté from the mastoid or 
occipital cortex, which is used to obliterate the mastoidectomy defect after the ear canal 
reconstruction2. To increase visualization during cholesteatoma removal, strategic cuts are made 
in the posterior ear canal allowing it to be removed. After cholesteatoma removal and 
tympanoplasty, the canal wall is replaced and the mastoid is obliterated with the autologous bone 
pâté. Obliteration of the mastoid physically supports the reconstructed posterior ear canal and 
reduces the nitrogen absorbing mucosa of the mastoid epithelium, which has been implicated in 
the development of cholesteatoma2. 
Early in the description of the CWR procedure, postoperative mastoid infection was as 
high as 14.3%2. Subsequently, autologous bone pâté was only harvested from the squamous 
portion of the temporal bone or the occipital bone without contamination with mastoid air cells 
and institution of aggressive postoperative antibiotic treatment led to a decrease in the infection 
rate to 4.5%2.   
To date, there is little known about the composition and viability of the bone pâté used to 
obliterate the mastoid during CWR. Autologous bone pâté is harvested with cutting burs and 
improving the viability of the bone pâté may also facilitate bone healing and reduce 
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postoperative infections. Here we investigated how otologic bur size and design impacts the 
viability of human cortical bone pâté.  
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Methods 
Our study was IRB-expedited through standard review (IRB Protocol #: 1502682884). Written 
consent was obtained for tissue analysis from all patients or their guardians. Our laboratory IBC 
protocol (IBC #: IN-675) was also approved. 
Harvesting Bone Pâté 
Bone pâté was harvested during CWR tympanomastoidectomy procedures from the 
squamous portion of the temporal bone or the occipital bones of both adults and children. 
Samples were collected using four otologic burs in a random order of sequence and were 
collected only at the start of a drilling procedure to ensure only cortical bone pâté would be 
collected. Drill burs were provided by Stryker Corporation (Kalamazoo, Michigan). The four 
different burs included the 6 mm 2Flute, 4 mm 2Flute, 6 mm multiflute, and 4 mm multiflute.  
Bone pâté was collected with a sterile tongue blade and placed directly into culture medium. 
Approximately 10 mg of bone pâté from each bur was placed in a unique 50 mL conical vial 
containing 30 mL of serum-free media (SFM) for transport to a cell culture lab and was plated or 
fixed within 12 hours after collection. The SFM consisted of Advanced DMEM/F12 with 100 
U/mL penicillin and 100 ug/mL streptomycin. 
Determination of Bone Fragment Size 
Bone pâté samples were fixed in 10% neutral-buffered formalin for 48 hours and embedded 
in OCT. 3.5-µm sections were cut and stained with hematoxylin and eosin (H&E) with orange G 
and phloxine. Sections were imaged to determine the bone fragment size distribution for each 
drill bur type. Samples were de-identified and assigned a random number to blind the imaging 
and imaging analysis process. All sections were viewed on a Leica DM LB compound 
microscope outfitted with a Q-Imaging Micropublisher Cooled CCD color digital camera. 
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Images were captured and analyzed using Bioquant software v. 15.1 (Bioquant Image Analysis 
Corp, Nashville , TN). The individual bone fragment surface area measurements were collected 
into a Prism 6 spreadsheet. Statistical analysis was done using GraphPad Prism program 
version6. Fragment surface area lengths of >35 μm2 were calculated as these represented the 
largest solitary fragments. A two-tailed Student’s t-test was used to determine the significance of 
the results. 
In vitro culture of bone pâté 
Bone pâté samples in SFM medium were placed in a cell culture hood where the SFM 
was vacuum aspirated.  25 mL of phosphate buffered saline (PBS) were added to each conical 
vial.  The samples were vortexed for 10 seconds after which the vials were kept still for 30 
seconds to allow for any undesired hematopoetic tissue to rise. The PBS was then vacuum 
aspirated.  This process was repeated twice until the bone samples appeared ivory white3.  All 
aspirations were performed with care to avoid accidental aspiration of bone pâté. 
Uncoated 60 mm cell culture dishes were plated with 5 mL of complete media, followed 
by ~10 mg of the bone pâté sample collected with a sterilized microspatula from the conical vial.  
The complete media consisted of Advanced DMEM/F12 with 10% fetal bovine serum, 2 mM 
GlutaMAX, 100 U/mL penicillin, and 100 ug/mL streptomycin. The bone pâté culture plates 
were kept in a 5% CO2, 37°C incubator for 3-4 weeks. The media was changed once a week 
during the first two weeks of culture and twice weekly thereafter. Within 4 weeks the culture 
specimens were analyzed to understand the cell types present. This analysis was conducted 
through staining, RT-PCR, and further culture on osteogenic media (PromoCell Mesenchymal 
Stem Cell Osteogenic Differentiation Medium, Catalog Number: C-28013). 
In-vitro Testing of Osteoblast Characteristics 
Cortical Bone Viability 
 7 
After 14 days in culture, non-adherent bone pâté fragments were removed from the cell 
culture plates using a P1000 micropipette with a wide-mouthed tip to leave only adherent cells 
and adherent bone fragments. Twice, 5 mL of PBS were carefully added and aspirated via the 
wide-tipped micropipette to ensure the full removal of all unattached bone fragments.  5 mL of 
fresh complete media was restored to the plates.  
The osteogenic capacity of the sample was evaluated by replacing the complete media 
with osteogenic media when the cells reached confluency. After 3 weeks in osteogenic media 
with twice weekly media replacement the cultures were stained for alkaline phosphatase or with 
alizarin red to determine calcium/phosphate crystal formation.   
For alkaline phosphatase staining the cells were washed once with PBS then fixed with 2 
mL of neutral buffered formalin. After 60 seconds the formalin was aspirated and replaced with a 
washing buffer of 0.05% Tween in PBS. The washing buffer was aspirated and replaced with a 
BCIP/NBT (5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium) solution. This 
solution was incubated in the dark at room temperature for 10 minutes. The plate was washed 
once with washing buffer followed by PBS. The stain was immediately imaged4. 
For alizarin red staining the cells were fixed using 2 mL of 10% neutral buffered formalin 
per plate. The plates were then washed twice using 2 mL of PBS. Alizarin Red (4.1 pH) was 
added to each plate and kept on the plates for 45 minutes. The stained plates were then washed 
three times with 2 mL of ddH20 and immediately imaged4. 
Counting Cultured Viable Osteoblasts  
 After 3-4 weeks of culture, before significant logarithmic growth, the wet bone pâté from 
each plate was removed through multiple PBS washes and deposited in a pre-weighed container.   
The bone pâté cultured cells were then trypsinized and passed through a cell strainer to filter out 
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all bone fragments. These cell suspensions were manually counted using a hemocytometer. The 
pre-weighed container with discarded bone pâté was then vacuum aspirated, set aside, and dried 
overnight to obtain a dry bone mass that was used to normalize the cell count data.  A two-tailed 
Student’s t-test was used to determine the significance of the results. 
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RESULTS 
 The four burs used in this study vary by head diameter (6 mm vs. 4 mm) and with respect 
to the cutting design (Figure 1). The 2Flute burs have 2 cutting flutes while the multi-fluted burs 
have 8 flutes (Figure 1). In addition, the angulation of the flutes around the head of the bur is 
increased in the multi-fluted burs compared to the 2Flute burs (Figure 1). Finally, the 6 mm burs 
have a 50% larger diameter than the 4 mm burs.  
 Bone pâté was harvested from patients undergoing CWR using the 4 various burs. Bone 
pâté fragments varied in size based on bur size and bur shape. Representative images of bone 
pâté fragments are shown (Figure 2 A-D). The surface areas of individual bone pâté fragments 
from each bur were quantified. The 6 mm 2Flute bur generated the larger bone pâté fragments 
(Figure 2E).  Bone pâté fragments were significantly larger when harvested with 2Flute bur 
compared to multiflute burs at both 6 mm diameter (112,632 ± 14,216 μm2, n = 32 vs. 66,637 ± 
8,387 μm2, n = 16; mean ± SE; P < 0.05) and 4mm diameter (70,158 ± 8,131 μm2, n = 35 vs. 
50,060 ± 3,198 μm2, n = 21, mean ± SE; P < 0.05, Figure 2E). Interestingly, bone pâté fragments 
produced by the 4 mm 2Flute were not significantly different in size compared to the 6 mm 
multi-fluted bur despite having a bur diameter that is 50% smaller (Figure 2E).  This finding 
implicates that the bur shape (i.e. 2Flute) is integral in obtaining large bone pâté fragments.  
 Next we analyzed the ability of surviving cells to be cultured from the bone pâté under 
the 4 bur conditions using equal amounts of bone pâté (Figure 3 A-D). Bur size and shape 
appears to be correlated with the number of viable bone cells in an autograft. Generally, the 
adherent cells of the 6 mm 2 flute were more numerous and exhibited sheeting before the other 
burs. Representative images of each bur after three weeks of in-vitro culture can be seen in 
Figure 3 A-D. After 3 weeks in culture, cell counts were significantly higher when harvested 
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with 2Flute burs compared to multiflute burs at both 6 mm diameter (48.7 ± 3 vs. 31.8 ± 3 
cells/μg bone; P < 0.05) and 4 mm diameter (27.6 ± 1.2 vs. 8.8 ± 1.2 cells/μg bone; P < 0.05; 
Figure 3E). The number of cultured cells was not significantly different between the 4 mm 
2Flute bur and the 6 mm multiflute bur, despite the bur being 50% smaller in diameter (Figure 
3E). 
 Next, we analyzed the cells for molecular markers of bone derived cells. Alkaline 
phosphatase, an enzyme highly expressed in osteoblasts, was observed in most of the cells 
(Figure 4 A-B). This demonstrates that human autograft bone pâté fragments harbor surviving 
osteoblasts. Cells derived from all four bur conditions exhibited similar expression of alkaline 
phosphatase.   
 We next determined if these cultured cells possessed the ability to generate osteoid or 
new bone in culture. Bone pâté-derived cells were cultured in an osteogenic media in the 
presence of bone pâté fragments. At day 31, it appears that the cell density is higher around the 
bone pâté fragments (Figure 4C, d31). This cellular density expands peripherally around the 
bone fragment at d45 (Figure 4D, d45). Alizarin Red is a stain used to detect new osteoid or 
bone formation. We observed new osteoid deposits throughout the plate, but most intensely 
around each bone pâté fragments (Figure 5E, d46) suggesting that bone formation or cell 
proliferation is accelerated in the presence of bone pâté fragment. In addition, bone pâté-derived 
cells cultured in the absence of bone pâté fragments also exhibited Alizarin Red osteoid (data not 
shown).  
Finally, we analyzed the gene expression of the bone pâté-derived cells in culture. 
Alkaline Phosphatase, Collagen 1a, Osteonectin, and Osteocalcin were all expressed in the 
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cultured cell (Figure 5).  These markers are all highly expressed in osteoblasts with osteocalcin 
being exclusively expressed by osteoblasts.    
Human autologous bone harvested with the 6 mm 2Flute bur is observed on postoperative 
imaging of the mastoid after a primary canal wall reconstruction tympanomastoidectomy with 
mastoid obliteration procedure (Figure 6).   
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DISCUSSION 
 Bone pâté autografts produced from cortical bone with 2Flute otologic burs contain larger 
bone fragments than multiflute otologic burs. The 2Flute-harvested bone pâté fragments are not 
only larger but contain more surviving osteoblasts, which facilitate new bone formation. This 
suggests that bone derived from 2Flute otologic burs is more viable for replacement into the 
mastoid during CWR than multiflute otologic burs. This improvement in bioactivity has 
implications for improved bone healing in addition to potentially decreasing the rates of 
absorption and infection. 
 Autografts are often the material of choice when performing cranial reconstruction. In 
cranioplasty procedures bone autografts are less likely to be infected or resorbed when compared 
to calcium phosphate bone cement and demineralized bone matrix5. Particulate bone pâté 
autografts are a further refinement reported to reduce osseous defects from 24 percent to 9 
percent when compared to split calvarial autografts in cranioplasty6. Osteocytes are able to 
remain viable after drilling and may participate in bone reconstruction after autograft placement.  
Furthermore, the increased surface area to volume ratio of particulate autografts improves 
diffusion of nutrients and growth factors to accelerate integration of the autograft7. 
While the smaller particulate autograft is an improvement over the whole bone autograft, 
our study suggests increasingly small particulate bone fragments have more limited viability. 
The 2Flute burs produced larger bone fragments than the multiflute burs. This is likely due to the 
increased clearance between the 2Flute bur’s cutting lips. These relatively large fragments 
improved the viability of osteocytes as demonstrated by normalized in-vitro cell counts. Fresh 
autografts have a lower rate of infection and better preservation of desired anatomy than grafts 
with fewer viable cells such as frozen or pre-harvested grafts5. The bone harvest was made 
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carefully to ensure the bone pâté was composed of only cortical bone as cancellous bone is more 
cellular and could skew the results of the cell counts.   
The initial phase of bone healing is characterized by neovascularization with increased 
osteoclast activity and resorption.  However, within days osteogenesis will also begin.  During 
the osteogenic period particulate autografts participate in both internal mineralization and 
creeping mineralization by surrounding bone at the edges of the graft8. We observed that 
particulate bone pâté autografts produce viable cells that may participate in osteogenesis. Our 
cultured bone pâté cells demonstrate characteristics of osteoblasts including alkaline phosphatase 
activity, the ability to form osteoid matrix, and osteoblast RNA expression especially when 
induced by mineralization media. These capacities may be induced by in vivo growth factors 
during post-surgical bone healing. 
Our study’s findings are limited by the use of an in-vitro model. In-vitro human 
osteoblast culture is a powerful, well-studied method with more flexibility than an animal model. 
Although bone pâté cultures can be stimulated to generate new bone with osteogenic media, 
autograft osteocytes and osteoblasts may behave differently in vivo. Further study of bone pâté 
autografts in an animal temporal bone model could further elucidate their post-operative 
behavior. Also, we did not perform a randomized trial of CWR using various burs to determine 
bone healing and infections rates. 
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CONCLUSION 
Innovations in surgical drill bur manufacture have expanded the skull base surgeon’s tool 
kit. In this study we have found that the 2Flute otologic drill bur produces more viable bone 
fragments.  Future studies are need to determine if this leads to improved bone healing. This 
improvement could be useful in autologous bone graft procedures such as canal wall 
reconstruction2, cranioplasty4-6,9, and occipitocervical fusion10,11 among others.  
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FIGURE LEGENDS 
Figure 1. Visual representation of burs tested (mm = millimeters) 
Figure 2.  (A-D) Representative histologic sections of bone pâté fragments produced by each bur  
(E) Bone pâté fragment surface area distribution for each bur. (mm = millimeters, * = P < 0.05,  
NS = non-significant) 
Figure 3.  (A-D) Representative images of adherent cells after 2 weeks of culture after 
harvesting with various burs. (B) Cell counts of adherent cells at 2 weeks in culture of bone pâté 
fragments obtained with various burs. (mm = millimeters, μg = micrograms, * = P < 0.05, NS = 
non-significant) 
Figure 4.  (A, B) Alkaline Phosphatase staining of cultured cells from 6 mm and 4 mm 2Flute 
burs. (C, C’, D, D’) In-vitro culture bone cell growth from day 31 to day 45 in culture (Arrows). 
(E, E’) Alizarin red positive osteoid at 46 days in culture. Inset (dashed box) = 40x 
magnification.  d = day 
Figure 5.  RT-PCR analysis of osteoblast related genes from adherent cells from bone pâté 
fragments after 38 days of culture (bp = base pairs of DNA). L27 is a control gene. 
Figure6.  Representative sagittal CT image of a patient who has undergone CWR with mastoid 
obliteration with bone pâté harvested with 6 mm 2Flute bur. Posterior ear canal cuts (arrows) and 
bone pâté (*) are noted.   
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